National Institutes of Health Consensus Developmen... [Hepatology. 2002]

Cited by 60 PubMed Central articles

Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study.
Gramenzi A, Cursaro C, Margotti M, Balsano C, Spaziani A, Anticoli S, Loggi E, Salerno M, Galli S, Furlini G, et al. World J Gastroenterol. 2009 Dec 21; 15(47):5946-52.

[World J Gastroenterol. 2009]
Hepatitis C virus (HCV) genotype 1 subtype identification in new HCV drug development and future clinical practice.
Chevaliez S, Bouvier-Alias M, Brillet R, Pawlotsky JM. PLoS One. 2009 Dec 8; 4(12):e8209. Epub 2009 Dec 8.

[PLoS One. 2009]
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.
Perales C, Agudo R, Tejero H, Manrubia SC, Domingo E. PLoS Pathog. 2009 Nov; 5(11):e1000658. Epub 2009 Nov 13.

[PLoS Pathog. 2009]
» See all...

Related Articles
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Your browsing activity is empty.

Activity recording is turned off.